Literature DB >> 19144478

Relationship of stimulated saliva 17beta-estradiol and oral dryness feeling in menopause.

Farzaneh Agha-Hosseini1, Iraj Mirzaii-Dizgah, Arash Mansourian, Mina Khayamzadeh.   

Abstract

OBJECTIVES: The aim of this study was to compare stimulated whole saliva 17beta-estradiol of menopausal women with/without oral dryness (OD) feeling, and evaluate the relationship between saliva 17beta-estradiol and severity of OD feeling.
METHODS: A case-control study was carried out in 76 selected menopausal women aged 41-77 years with or without OD feeling (38 as case and 38 as control) conducted at the Clinic of Oral Medicine, Tehran university of medical sciences. Paraffin-stimulated saliva samples were obtained by expectoration. Xerostomia inventory (XI) score was used as an index of OD feeling severity. The saliva 17beta-estradiol concentration was measured by ELISA. Statistical analysis of Student's t-test and Spearman correlation was used.
RESULTS: No significant difference was found in stimulated whole saliva flow rate between the two groups, but the mean concentration and output of saliva 17beta-estradiol were significantly lower in case than control. There was significant negative correlation between XI score and stimulated whole saliva concentration (r=-0.391, P=0.004) and output (r=-0.302, P=0.002) of 17beta-estradiol in menopausal women.
CONCLUSIONS: It seems that there is a negative correlation between OD feeling severity and stimulated whole saliva 17beta-estradiol in menopausal women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144478     DOI: 10.1016/j.maturitas.2008.10.016

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  12 in total

1.  Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction.

Authors:  Iraj Mirzaii-Dizgah; Seyed Fakhreddin Hejazi; Esmail Riahi; Mohammad Mohsen Salehi
Journal:  Clin Oral Investig       Date:  2011-06-18       Impact factor: 3.573

2.  Stimulated and unstimulated saliva progesterone in menopausal women with oral dryness feeling.

Authors:  Iraj Mirzaii-Dizgah; Farzaneh Agha-Hosseini
Journal:  Clin Oral Investig       Date:  2010-07-21       Impact factor: 3.573

3.  Retrograde ductal administration of the adenovirus-mediated NDRG2 gene leads to improved sialaden hypofunction in estrogen-deficient rats.

Authors:  Yan Li; Changhao Liu; Wugang Hou; Yang Li; Ji Ma; Kaifeng Lin; Zhenqiang Situ; Lize Xiong; Shaoqing Li; Libo Yao
Journal:  Mol Ther       Date:  2013-12-17       Impact factor: 11.454

4.  Serum and saliva collagenase-3 (MMP-13) in patients with oral lichen planus and oral squamous cell carcinoma.

Authors:  Farzaneh Agha-Hosseini; Iraj Mirzaii-Dizgah
Journal:  Med J Islam Repub Iran       Date:  2015-06-07

Review 5.  Oral health and menopause: a comprehensive review on current knowledge and associated dental management.

Authors:  P Dutt; S Chaudhary; P Kumar
Journal:  Ann Med Health Sci Res       Date:  2013-07

6.  Oral findings in postmenopausal women attending dental hospital in Western part of India.

Authors:  Patil Santosh; Sinha Nidhi; Kaswan Sumita; Rahman Farzan; Doni Bharati; Kp Ashok
Journal:  J Clin Exp Dent       Date:  2013-02-01

Review 7.  Menopause and oral health.

Authors:  Vanita Suri; Varun Suri
Journal:  J Midlife Health       Date:  2014-07

Review 8.  An evidence-based review literature about risk indicators and management of unknown-origin xerostomia.

Authors:  Farzaneh Agha-Hosseini; Mahdieh-Sadat Moosavi
Journal:  J Dent (Tehran)       Date:  2013-05

9.  Evaluation of Xerostomia and salivary flow rate in Hashimoto's Thyroiditis.

Authors:  Farzaneh Agha-Hosseini; Nooshin Shirzad; Mahdieh-Sadat Moosavi
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-01-01

Review 10.  Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms.

Authors:  Jessica E Brandt; Roberta Priori; Guido Valesini; DeLisa Fairweather
Journal:  Biol Sex Differ       Date:  2015-11-03       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.